The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
On June 4, Bernstein Liebhard LLP announced a securities class action lawsuit against Zoetis Inc. on behalf of investors. On the same day, Pomerantz LLP launched an investigation into Biogen after its Alzheimer's therapy study results missed the primary endpoint. An investigation was also opened into Cencora following its Q2 2026 financial results that missed estimates and a reduction in full-year guidance. Additionally, Johnson Fistel began an investigation into potential federal securities law violations by Simulations Plus, following a revenue guidance cut, an impairment charge, and a dispute with the company's auditor.